虾青素
肌萎缩侧索硬化
临床试验
医学
疾病
药理学
生物
内科学
类胡萝卜素
食品科学
作者
Timothy Fullam,Carmel Armon,Paul E. Barkhaus,Benjamin Barnes,Morgan Beauchamp,Michael Benatar,Tulio E. Bertorini,Robert Bowser,Mark B. Bromberg,Javier Mascías Cadavid,Gregory T. Carter,Mazen M. Dimachkie,Dave Ennist,Eva L. Feldman,Terry Heiman‐Patterson,Sartaj Jhooty,Isaac Lund,Christopher McDermott,Gary L. Pattee,Dylan Ratner,Paul Wicks,Richard Bedlack
标识
DOI:10.1080/21678421.2023.2171302
摘要
ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here we review astaxanthin which has plausible mechanisms for slowing ALS progression including antioxidant, anti-inflammatory, and anti-apoptotic effects. While there are no ALS-specific pre-clinical studies, one verified "ALS reversal" occurred in a person using a combination of alternative therapies which included astaxanthin. There have been no trials of astaxanthin in people living with ALS. Natural astaxanthin appears to be safe and inexpensive. Based on the above information, we support further pre-clinical and/or clinical trials of astaxanthin in disease models and PALS, respectively, to further elucidate efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI